Early diagnosis and appropriate treatment for carbapenem-resistant Klebsiella pneumoniae (CR-Kp) infection is a big challenge\nfor clinicians due to its high mortality. Every effort has been made to improve its clinical outcomes. However, treatment according\nto synergy susceptibility testing has never been reported in the literature. We reported a 29-year-old systemic lupus erythematosus\nfemale with CR-Kp blood stream infection. We highlighted the identification by next generation sequencing and treatment\naccording to synergy susceptibility testing in the case.
Loading....